Biogen Inc.(BIIB)
(Earnings Call Insights) Biogen outlines 67% launch product growth and signals expanded pipeline momentum amid strong Q3 results
Biogen Non-GAAP EPS of $4.81 beats by $0.93, revenue of $2.54B beats by $200M
Biogen's Comeback_Why The Bulls Are Finally Winning Again (StrongBuy)
Biogen Inc. (BIIB): Strong print as we look to Leqembi and pipeline drivers (Buy)
